LivaNova (LIVN) Depreciation & Amortization (CF) (2015 - 2026)

LivaNova (LIVN) reported Depreciation & Amortization (CF) of $8.3 million for Q1 2026, up 29.3% on a YoY basis from $6.4 million in Q1 2025, and up 9.86% sequentially from $7.6 million in Q4 2025.

LivaNova (LIVN) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

LivaNova (LIVN) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $8.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 29.3% year-over-year to $8.3 million; the trailing twelve-month figure through Mar 2026 stood at $30.4 million (up 57.72% YoY), and the FY2025 full-year result was $28.6 million, up 65.95% from the prior year.
  • Depreciation & Amortization (CF) grew to $8.3 million in Q1 2026, from $7.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $8.3 million in Q1 2026 to a low of $4.3 million in Q4 2024.
  • A 5-year average of $6.2 million and a median of $6.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) tumbled 32.97% in 2024 and surged 77.68% in 2025, its largest moves.
  • Tracing LIVN's Depreciation & Amortization (CF) over 5 years: stood at $6.2 million in 2022, then climbed by 1.85% to $6.3 million in 2023, then plunged by 32.97% to $4.3 million in 2024, then surged by 77.68% to $7.6 million in 2025, then increased by 9.86% to $8.3 million in 2026.
  • Business Quant data shows LIVN's Depreciation & Amortization (CF) at $8.3 million in Q1 2026, $7.6 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 LivaNova 4.30 Bn 3.76 Bn 243.75 Mn 8.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.30 Mn
Mar 31, 2026 8.30 Mn
Dec 31, 2025 7.56 Mn
Dec 31, 2025 7.56 Mn
Sep 30, 2025 7.72 Mn
Sep 30, 2025 7.72 Mn
Jun 30, 2025 6.87 Mn
Jun 30, 2025 6.87 Mn
Mar 31, 2025 6.42 Mn
Mar 31, 2025 6.42 Mn
Dec 31, 2024 4.25 Mn
Dec 31, 2024 4.25 Mn
Sep 30, 2024 4.35 Mn
Sep 30, 2024 4.35 Mn
Jun 30, 2024 4.29 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 4.33 Mn
Mar 31, 2024 4.33 Mn
Dec 31, 2023 6.34 Mn
Dec 31, 2023 6.34 Mn